This six-part program provides an overview of key concepts and skills for clinicians facing common challenges in the management of patients with chronic pain, including reducing the risks of opioids and addressing opioid use disorder.
The objective of this guideline is to provide clinical recommendations for the initiation, maintenance and discontinuation of buprenorphine/naloxone maintenance treatment in the ambulatory treatment of adults and adolescents with opioid dependence in Ontario.
Provided by the Centre for Addiction and Mental Health (CAMH) and the College of Physicians and Surgeons of Ontario (CPSO)